Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System for Home Hemodialysis Prior to Market Authorization

NCT04198012 is registered in ClinicalTrials.gov with Deka Research and Development as lead sponsor.

NCT NCT04198012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04198012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System for Home Hemodialysis Prior to Market Authorization
Lead sponsor
Deka Research and Development
Phase
Not applicable
Overall status
Completed
Start date
December 16, 2019
Completion date
April 5, 2024
Enrollment
25 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease